UBS Group’s Envoy Medical COCH Stock Holding History
Bought
Maintained
Sold
Other funds holding COCH
UBS Group's COCH Position: Q3 2026 in Review
UBS Group reduced its Envoy Medical (COCH) stake by 75% in Q3 2026, selling an estimated $102K and leaving 4,738 shares worth $32.3K. The position accounts for ﹤0.01% of the portfolio, ranked #8038.
UBS Group first reported a position in COCH in Q2 2021 and has held it in 16 quarters since. The position peaked at $151K in Q2 2026. 12 funds tracked by Wall St. Rank hold COCH as of Q3 2026.
- UBS Group held 4,738 shares of Envoy Medical worth $32.3K as of Q3 2026.
- UBS Group sold 14,346 Envoy Medical shares in Q3 2026, an estimated $102K.
- Envoy Medical made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #8038 holding.
- UBS Group first reported a position in Envoy Medical in Q2 2021 and has held it in 16 quarters since.
- UBS Group's Envoy Medical position peaked at $151K in Q2 2026.
- 12 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.